Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC
Clinical trial NCT06126822 · RECRUITING
Trial details
- NCT number
- NCT06126822
- Sponsor
- Institute of Tropical Medicine, Belgium
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-25
- Primary completion
- 2026-10-01
- Enrollment
- 624
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.